Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.

Sharkey-Mathis PK, Velez J, Fetchick R, Graybill JR.

J Acquir Immune Defic Syndr. 1993 Jul;6(7):809-19.

PMID:
8389850
2.

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

Wheat J, Hafner R, Wulfsohn M, Spencer P, Squires K, Powderly W, Wong B, Rinaldi M, Saag M, Hamill R, Murphy R, Connolly-Stringfield P, Briggs N, Owens S; National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators.

Ann Intern Med. 1993 Apr 15;118(8):610-6.

PMID:
8383934
3.

New methods of delivery of amphotericin B.

Schmitt HJ.

Clin Infect Dis. 1993 Nov;17 Suppl 2:S501-6. Review.

PMID:
8274617
5.

Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone.

Allendoerfer R, Magee DM, Deepe GS Jr, Graybill JR.

Infect Immun. 1993 Feb;61(2):714-8.

6.

Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome.

Norris S, Wheat J, McKinsey D, Lancaster D, Katz B, Black J, Driks M, Baker R, Israel K, Traeger D, et al.

Am J Med. 1994 Jun;96(6):504-8.

PMID:
8017447
7.

Visceral leishmaniasis following treatment with liposomal amphotericin B.

McBride M, Linney M, Claydon EJ, Weber J.

Clin Infect Dis. 1994 Aug;19(2):362. No abstract available.

PMID:
7986926
9.

Adoptive transfer of immunity to Histoplasma capsulatum in athymic nude mice.

Williams DM, Graybill JR, Drutz DJ.

Sabouraudia. 1981 Mar;19(1):39-48.

PMID:
6452707
10.

Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.

Dismukes WE, Stamm AM, Graybill JR, Craven PC, Stevens DA, Stiller RL, Sarosi GA, Medoff G, Gregg CR, Gallis HA, Fields BT Jr, Marier RL, Kerkering TA, Kaplowitz LG, Cloud G, Bowles C, Shadomy S.

Ann Intern Med. 1983 Jan;98(1):13-20.

PMID:
6293361
11.

Liposomes as carriers of antimicrobial agents.

Lopez-Berestein G.

Antimicrob Agents Chemother. 1987 May;31(5):675-8. Review. No abstract available.

12.
13.

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.

Wheat LJ, Connolly-Stringfield PA, Baker RL, Curfman MF, Eads ME, Israel KS, Norris SA, Webb DH, Zeckel ML.

Medicine (Baltimore). 1990 Nov;69(6):361-74. Review.

PMID:
2233233
14.

Amphotericin B: delivery systems.

Brajtburg J, Powderly WG, Kobayashi GS, Medoff G.

Antimicrob Agents Chemother. 1990 Mar;34(3):381-4. Review. No abstract available.

15.

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial.

Meunier F, Prentice HG, Ringdén O.

J Antimicrob Chemother. 1991 Oct;28 Suppl B:83-91.

PMID:
1778895
16.

Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.

Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey GP.

Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):665-8.

PMID:
1748123
17.

Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.

Tucker RM, Denning DW, Hanson LH, Rinaldi MG, Graybill JR, Sharkey PK, Pappagianis D, Stevens DA.

Clin Infect Dis. 1992 Jan;14(1):165-74.

PMID:
1315160

Supplemental Content

Support Center